General MedicationsORALGeneric
ZYFLO
ZILEUTON
Standard Dose
600MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary
Approval overview ZYFLO is listed in Drugs@FDA under application 020471 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ZILEUTON Form and strength TABLET;ORAL - 600MG Sponsor CHIESI Submission history Latest submission status date: 2012-06-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZYFLO is listed in Drugs@FDA under application 020471 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ZILEUTON Form and strength TABLET;ORAL - 600MG Sponsor CHIESI Submission history Latest submission status date: 2012-06-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.